NCT03152123View on ClinicalTrials.gov

Determination the Abuse Potential of Pitolisant in Healthy, Non-Dependent Recreational Stimulant Users

PHASE1CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

March 15, 2017

Primary Completion Date

October 23, 2017

Study Completion Date

October 23, 2017

Conditions
HealthyDrug Abuse
Interventions
DRUG

Pitolisant

Pitolisant 40 mg or 240 mg (tablets over-capsuled)

DRUG

Placebos

tablets over-capsuled

DRUG

Phentermine

Phentermine 60 mg (capsule over-capsuled)

Trial Locations (1)

M5V 2T3

INC Research, Toronto

Sponsors

Lead Sponsor

Bioprojet
All Listed Sponsors
lead

Bioprojet

OTHER